DepoMed (DEPO) PT Bumped to $19 at Piper Jaffray, Remains Sidelined
Tweet Send to a Friend
Piper Jaffray analyst David Amsellem bumped his price target on DepoMed Inc (NASDAQ: DEPO) to $19.00 (from $18.00) but maintained ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
